Genetic association of FMRP targets with psychiatric disorders

scientific article published on 19 October 2020

Genetic association of FMRP targets with psychiatric disorders is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41380-020-00912-2
P698PubMed publication ID33077856

P50authorMichael OwenQ17198421
George KirovQ30004103
Michael C O'DonovanQ30410265
Nicholas E CliftonQ47162727
Antonio F PardiñasQ47232297
Andrew PocklingtonQ60666480
Jeremy HallQ61800399
P2093author name stringPeter A Holmans
James T R Walters
Arianna Di Florio
Elliott Rees
Janet C Harwood
P2860cites workThe Kraepelinian dichotomy - going, going... but still not goneQ22241683
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseQ22251067
Rare chromosomal deletions and duplications increase risk of schizophreniaQ22337245
The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BPQ24314573
Altered synaptic plasticity in a mouse model of fragile X mental retardationQ24530695
Biological insights from 108 schizophrenia-associated genetic lociQ24561833
CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1Q24603800
FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autismQ24631425
A global reference for human genetic variationQ25909434
Analysis of protein-coding genetic variation in 60,706 humansQ26831376
Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.Q26866506
Evidence that fragile X mental retardation protein is a negative regulator of translationQ28117211
FMRP targets distinct mRNA sequence elements to regulate protein expressionQ28117931
Synaptic, transcriptional and chromatin genes disrupted in autismQ28250800
The contribution of de novo coding mutations to autism spectrum disorderQ28250812
Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in SchizophreniaQ28262977
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeQ28273791
Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplicationsQ28304430
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapsesQ28576233
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric diseaseQ89938769
Widespread RNA editing dysregulation in brains from autistic individualsQ90597084
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophreniaQ92611022
The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuitsQ28588310
The fragile X mental retardation protein inhibits translation via interacting with mRNAQ28588486
Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptorsQ28771397
CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formationQ28910185
A framework for the interpretation of de novo mutation in human diseaseQ29031873
De Novo Gene Disruptions in Children on the Autistic SpectrumQ29394534
Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndromeQ29616495
De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia.Q30454132
MAGMA: generalized gene-set analysis of GWAS dataQ30935493
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.Q33398247
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressantsQ33604879
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disabilityQ33650848
Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.Q33772616
A polygenic burden of rare disruptive mutations in schizophreniaQ34060200
Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequencesQ34211875
De novo mutations in schizophrenia implicate synaptic networksQ34540372
Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genesQ34566077
Copy number variation in schizophrenia in SwedenQ34742638
Activity-dependent FMRP requirements in development of the neural circuitry of learning and memoryQ35228888
Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility geneQ35296003
Increased co-expression of genes harboring the damaging de novo mutations in Chinese schizophrenic patients during prenatal developmentQ36371011
Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.Q36498006
Exome arrays capture polygenic rare variant contributions to schizophrenia.Q36581392
Psychiatric classifications: validity and utilityQ36657877
Psychiatric gene discoveries shape evidence on ADHD's biologyQ36763139
De novo variants in sporadic cases of childhood onset schizophreniaQ36902721
Support for the involvement of large copy number variants in the pathogenesis of schizophreniaQ37147142
Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophreniaQ37407215
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical networkQ37487752
Analysis of copy number variations at 15 schizophrenia-associated loci.Q37541157
Expansion of the Gene Ontology knowledgebase and resourcesQ37556864
Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stabilityQ37616726
Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorderQ37699386
Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticityQ38242794
New approaches to psychiatric diagnostic classificationQ38274354
Multifarious Functions of the Fragile X Mental Retardation ProteinQ38639448
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjectsQ39217627
Analysis of Intellectual Disability Copy Number Variants for Association With SchizophreniaQ39414858
Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophreniaQ40118681
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.Q40145512
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells.Q40524276
Exome Sequencing of Familial Bipolar DisorderQ40779420
Fmrp targets or not: long, highly brain-expressed genes tend to be implicated in autism and brain disordersQ41194358
Schizophrenia and the neurodevelopmental continuum:evidence from genomicsQ41658777
Roles of CREB in the regulation of FMRP by group I metabotropic glutamate receptors in cingulate cortex.Q42057289
Schizophrenia copy number variants and associative learningQ42325307
Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.Q43297720
NMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout miceQ45349101
FMRP acts as a key messenger for dopamine modulation in the forebrainQ46400113
Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouseQ47202657
Gene-set analysis shows association between FMRP targets and autism spectrum disorderQ47745129
The implications of the shared genetics of psychiatric disordersQ47895165
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.Q48392342
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.Q48569575
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.Q50301210
A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.Q50307286
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.Q52560096
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.Q52584632
Linking the SWI/SNF complex to prostate cancer.Q52644728
Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome.Q55287271
Increased exonic de novo mutation rate in individuals with schizophreniaQ59667688
Genome-wide association study identifies 30 loci associated with bipolar disorder.Q63433064
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regionsQ63433067
Targeted Sequencing of 10,198 Samples Confirms Abnormalities in Neuronal Activity and Implicates Voltage-Gated Sodium Channels in Schizophrenia PathogenesisQ64088951
Genetic and environmental influences on the cognitive outcomes of children with fragile X syndromeQ77747383
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memoryQ83225464
HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation proteinQ88398634
Postsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear NucleusQ89295073
P577publication date2020-10-19
P1433published inMolecular PsychiatryQ6895973
P1476titleGenetic association of FMRP targets with psychiatric disorders

Search more.